CAR-T cell therapy has shown promising results for multiple myeloma, especially for those with hard-to-treat cases. Here are some key points from my knowledge base:

- Effectiveness: In clinical trials, 2 out of 3 participants were in remission for at least one year
- Remission Rates: 14 out of 19 patients reached the Show Full Answer

CAR-T cell therapy has shown promising results for multiple myeloma, especially for those with hard-to-treat cases. Here are some key points from my knowledge base:

- Effectiveness: In clinical trials, 2 out of 3 participants were in remission for at least one year.
- Remission Rates: 14 out of 19 patients reached the highest level of remission, with no relapses reported among those followed for more than a year.
- Side Effects: Nearly every participant experienced side effects, but most were mild. However, about 85% experienced cytokine release syndrome (CRS), which can include fever, low blood pressure, and difficulty breathing.
- Availability: This treatment is only available at certified locations due to the need for specialized care.

It's important to discuss the risks and benefits with your doctor to determine if CAR-T cell therapy is right for you.

 This AI-generated response comes from MyMyelomaTeam and other selected sources. It is not a substitute for medical advice. Always ask your doctor about specific health concerns.

CAR-T Cell Therapy for Multiple Myeloma: What Is It? | MyMyelomaTeam

Gene-Based Therapy May Thwart a Tough Blood Cancer | MyMyelomaTeam